ANTICANCER AGENT AND CONCOMITANT DRUG WITH RADIATION IN CHEMORADIOTHERAPY, CONTAINING GOLD COMPLEX
To provide an anticancer agent or a concomitant drug with radiation in chemoradiotherapy containing a gold complex with an amino acid derivative as a ligand, and a novel gold complex that can be used in the anticancer agent or the concomitant drug with radiation in chemoradiotherapy.SOLUTION: An anticancer agent or a concomitant drug with radiation in chemoradiotherapy, containing a gold complex represented by the formula (1): L1-S-Au-(L2)m (1) (where L1 is an amino acid derivative, L2 is a heterocycle having -SH coordinated to Au shown in the formula (1), optionally having a further substituent, m is 0 or 1).SELECTED DRAWING: None.
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 15. Feb. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
KASHIWAKURA IKURO [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-02-15, Last update posted on www.tib.eu: 2024-02-22, Last updated: 2024-03-01 |
|---|
| Patentnummer: |
JP2021017451 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA011754044 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA011754044 | ||
| 003 | DE-627 | ||
| 005 | 20240301101334.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210622s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA011754044 | ||
| 035 | |a (EPA)JP2021017451 | ||
| 035 | |a (EPA)74563043 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a KASHIWAKURA IKURO |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ANTICANCER AGENT AND CONCOMITANT DRUG WITH RADIATION IN CHEMORADIOTHERAPY, CONTAINING GOLD COMPLEX |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2021-02-15, Last update posted on www.tib.eu: 2024-02-22, Last updated: 2024-03-01 | ||
| 520 | |a To provide an anticancer agent or a concomitant drug with radiation in chemoradiotherapy containing a gold complex with an amino acid derivative as a ligand, and a novel gold complex that can be used in the anticancer agent or the concomitant drug with radiation in chemoradiotherapy.SOLUTION: An anticancer agent or a concomitant drug with radiation in chemoradiotherapy, containing a gold complex represented by the formula (1): L1-S-Au-(L2)m (1) (where L1 is an amino acid derivative, L2 is a heterocycle having -SH coordinated to Au shown in the formula (1), optionally having a further substituent, m is 0 or 1).SELECTED DRAWING: None | ||
| 650 | 4 | |a C07F: Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium (metal-containing porphyrins c07d0487220000;macromolecular compounds c08) | |
| 650 | 4 | |a bio | |
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a C12Q: Measuring or testing processes involving enzymes, nucleic acids or microorganisms (immunoassay g01n0033530000); compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a YOSHINO HIRONORI |4 aut | |
| 700 | 0 | |a HONMA HIDEO |4 aut | |
| 700 | 0 | |a CHRISTOPHER ERNEST JOHN CORDONIER |4 aut | |
| 700 | 0 | |a SANO NAOYUKI |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 15. Feb. |
| 773 | 1 | 8 | |g year:2021 |g day:15 |g month:02 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/74563043/publication/JP2021017451A1?q=JP2021017451 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2021 |b 15 |c 02 | ||